A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0004|88|6|579-583

ISSN： 0009-9163

Source： CLINICAL GENETICS, Vol.88, Iss.6, 2015-12, pp. : 579-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population

By  

CLINICAL GENETICS, Vol. 88, Iss. 1, 2015-07 ,pp. : 74-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of macitentan for the treatment of pulmonary arterial hypertension

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1358, Iss. 1, 2015-11 ,pp. : 68-81

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostication in Pulmonary Arterial Hypertension with Submaximal Exercise Testing

By Khatri Vinod   Neal Jennifer E.   Burger Charles D.   Lee Augustine S.  

Diseases, Vol. 3, Iss. 1, 2015-02 ,pp. : 15-23

MDPI

Access to resources Recommend Favorite

De Novo Mutations in the BMPR2 Gene in Patients with Heritable Pulmonary Arterial Hypertension

By  

ANNALS OF HUMAN GENETICS, Vol. 79, Iss. 2, 2015-03 ,pp. : 85-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

By Leopold Jane A.   Maron Bradley A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 761-761

MDPI

Access to resources Recommend Favorite